adalimumab,infliximab
abbvie,janssen
['ibd']
anti-tnfs - opens telling us that they are still kicking for #ibd ! #aibd2022 
Gastroenterologist with focus on #IBD and quality improvement @utswnews (Tweets mine, not medical advice, of course)